Clinical trial

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1…

NCT00414518 · University of Colorado, Denver, Other · Completed

Key facts

NCT number NCT00414518
Title Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
Official title An Open-Label Randomized Clinical Trial to Evaluate the Efficacy and Safety of Short Course Antiretroviral Therapy for Acute or Recent HIV-1 Infection in Zimbabwe and the United States
Lead sponsor University of Colorado, Denver, Other
Collaborators National Institute of Allergy and Infectious Diseases (NIAID) NIH
Status Completed
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Tenofovir disoproxil fumarate/Emtricitabine, Lopinavir/Ritonavir
Enrollment 16
Start date Jan 1, 2007
Primary completion Feb 1, 2010
Completion Feb 1, 2010
First posted Dec 21, 2006
Last update posted Feb 20, 2013
Countries United States, Zimbabwe

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies